RecruitingNCT03792659
The EXPLORE MG Registry for Myasthenia Gravis
Exploring Outcomes and Characteristics of Myasthenia Gravis: The EXPLORE MG Registry
Sponsor
Yale University
Enrollment
800 participants
Start Date
Mar 30, 2016
Study Type
OBSERVATIONAL
Conditions
Summary
The purpose of this study is to create a Yale University Department of Neurology Myasthenia Gravis (MG) registry that will be used for current and future research projects involving the study of Myasthenia Gravis.
Eligibility
Min Age: 18 Years
Inclusion Criteria1
- Adult patients diagnosed with Myasthenia Gravis presenting to the Yale Department of Neurology for clinical care or research interventions will be invited to donate their biological specimens/clinical data.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERBlood Sample Draw
Approximately 100 cc (less than 1/2 cup) of blood will be drawn from both groups.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03792659
Related Trials
ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis
NCT0729417010 locations
ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod
NCT072844209 locations
A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases
NCT073041543 locations
Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis
NCT0641495440 locations
Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis
NCT072175878 locations